FMC delivered strong third-quarter results, with revenue and earnings exceeding expectations. Revenue grew 10% to $1.2 billion, driven by volume gains and price increases. New products contributed over 1/3 of revenue growth, with Plant Health posting 40% growth. Adjusted EBITDA increased 12% to $293 million, as operational discipline and price hikes offset supply chain headwinds. Adjusted earnings per share rose 17% to $1.43. Despite supply chain challenges, FMC met strong grower demand and expanded its EBITDA margins. The company raised its full-year 2021 guidance to revenue of $4.9-$5.1 billion, EBITDA of $1.29-$1.35 billion, and adjusted earnings per share of $6.59-$6.99. For Q4, FMC expects revenue growth of 19%, EBITDA growth of 29%, and EPS growth of 41%, with strong volume gains, continued pricing actions, and a favorable market outlook. Looking ahead to 2022, FMC anticipates continued revenue and earnings growth, driven by broad-based volume gains, pricing adjustments, and market expansion.